|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication November 29, 2005.
Revised February 9, 2006.
Accepted for publication February 27, 2006.
The human CYP1A1 and CYP1A2 genes on
chromosome 15 are orientated head-to-head and separated
by 23 kb intergenic spacer region. Thus the possibility
exists for sharing common regulatory elements contained
in the spacer region responsible for transcriptional
activation and regulation of the CYP1A1 and
CYP1A2 genes. In the present study, a reporter
gene construct containing -22.4 kb of the 5'
-flanking region of the CYP1A2 gene was
found to support
-naphthoflavone (BNF) and 3-
methylchoranthrene (3-MC)-mediated transcriptional
activation. The responsive region was also functional
in directing activation of the CYP1A1 promoter,
indicating that the region works bi-directionally to
govern transcriptional activation of both the
CYP1A1 and CYP1A2. To simultaneously
evaluate transcriptional activation of both genes, a
dual reporter vector was developed in which the spacer
region was inserted between two different reporter
genes, firefly luciferase and secreted alkaline
phosphatase. Transient transfection of the dual
reporter vector in HepG2 cells revealed increases in
both reporter activities after exposure of the cells to
BNF and 3-MC. Deletion studies of the spacer region
indicated that a region from -464 to -1829 of the
CYP1A1 gene works bi-directionally to enhance the
transcriptional activation of not only CYP1A1 but
also CYP1A2. In addition, a negative
bidirectional regulatory region was found existing from -
18909 to -21992 of the CYP1A1 gene. These data
established that induction of human CYP1A1 and
CYP1A2 are simultaneously controlled through
bidirectional and common regulatory elements.
Key words:
Promoter analysis, Cytochrome P450, Regulation - transcriptional, Regulation - xenobiotic, Ah receptor
This article has been cited by other articles:
![]() |
M. Nukaya, S. Moran, and C. A. Bradfield The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology PNAS, March 24, 2009; 106(12): 4923 - 4928. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Bass, P. Sienkiewicz, C. J. MacDonald, R. Y.S. Cheng, A. Sparatore, P. Del Soldato, D. D. Roberts, T. W. Moody, D. A. Wink, and G. C. Yeh Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells Clin. Cancer Res., March 15, 2009; 15(6): 1964 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Healan-Greenberg, J. F. Waring, D. J. Kempf, E. A. G. Blomme, R. G. Tirona, and R. B. Kim A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor Drug Metab. Dispos., March 1, 2008; 36(3): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Okino, L. C. Quattrochi, D. Pookot, M. Iwahashi, and R. Dahiya A Dioxin-Responsive Enhancer 3' of the Human CYP1A2 Gene Mol. Pharmacol., December 1, 2007; 72(6): 1457 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ihalmo, H. Schmid, M. P. Rastaldi, D. Mattinzoli, R. G. Langham, P. Luimula, R. Kilpikari, M. Lassila, R. E. Gilbert, D. Kerjaschki, et al. Expression of filtrin in human glomerular diseases Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1903 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Martinez-Jimenez, J. V. Castell, M. J. Gomez-Lechon, and R. Jover Transcriptional Activation of CYP2C9, CYP1A1, and CYP1A2 by Hepatocyte Nuclear Factor 4{alpha} Requires Coactivators Peroxisomal Proliferator Activated Receptor-{gamma} Coactivator 1{alpha} and Steroid Receptor Coactivator 1 Mol. Pharmacol., November 1, 2006; 70(5): 1681 - 1692. [Abstract] [Full Text] [PDF] |
||||